{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Philadelphia",
      "state": "PA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "71684",
      "recalling_firm": "Mutual Pharmaceutical Company,  Inc.",
      "address_1": "1100 Orthodox St",
      "address_2": "N/A",
      "postal_code": "19124-3168",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nartionwide",
      "recall_number": "D-1282-2015",
      "product_description": "Clonidine Hydrochloride Tablets, USP, 0.3 mg, 100 count HDPE bottles, Rx only, Mutual Pharmaceutical, Philadelphia, PA, NDC 53489-217-01",
      "product_quantity": "20,892 bottles",
      "reason_for_recall": "cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product, was dispensed in unauthorized rooms by the drug substance manufacturer",
      "recall_initiation_date": "20150709",
      "center_classification_date": "20150730",
      "termination_date": "20161013",
      "report_date": "20150805",
      "code_info": "Lot #: 6676701 and 6676801, exp 1/17"
    }
  ]
}